DUBLIN--(BUSINESS WIRE)--Elan Corporation, plc (NYSE: ELN) today announced that Eliseo Oreste Salinas, MD, MSc, has joined the company as Executive Vice President and Chief Medical Officer effective immediately, with responsibility for leading the company’s global development, clinical and medical initiatives. Dr. Salinas will be based at Elan’s South San Francisco campus, will be a member of the company’s executive leadership team, and will report to Elan President Carlos Paya, MD, PhD. As the company’s Chief Medical Officer, he will also retain specific accountabilities to Elan CEO Kelly Martin relating to patient safety.